Conditions: Acquired Immunodeficiency Syndrome HIV Infection
Keywords: Multicenter Open Label Non-Comparative Safety Study Of Maraviroc Treatment Experienced
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 209
Healthy volunteers: no

Brief summary:
To collect safety and tolerability data in a more diverse patient population of patients with HIV/Aids, who have limited therapeutic options.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Maraviroc
Intervention descriptions: intervention 1: Maraviroc should be dosed BID with total dose adjusted according to the other drugs the patient is taking. Maraviroc may be taken with or without food. The subject should only take missed doses if it is not within 6 hours prior to the planned next dose. No dose adjustment of OBT is required due to the presence of maraviroc.

Protocol document: